The University Clinical Centre of Serbia is an academic health science centre located in Belgrade, Serbia. It serves as the main medical centre for both Belgrade and the rest of Serbia.

There are 3,150 (2017) beds in Zvezdara University Medical Center.

During the past decade, Zvezdara University Medical Center conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 5 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zvezdara University Medical Center" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Galapagos NV" with 3 trials sponsored, "Eisai Limited" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored and "Vifor Pharma" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zvezdara University Medical Center" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Fresenius Medical Care North America" with 2 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Zvezdara University Medical Center" are "Ulcerative Colitis" (5 trials), "Crohn's Disease" (4 trials), "Chronic Kidney Disease Requiring Chronic Dialysis" (2 trials), "Colitis, Ulcerative" (2 trials) and "Epilepsy" (2 trials). Many other conditions were trialed in "Zvezdara University Medical Center" in a lesser frequency.

Most popular intervention types in "Zvezdara University Medical Center" are "Drug" (20 trials), "Biological" (2 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Filgotinib" (4 trials), "Guselkumab" (4 trials), "Guselkumab Dose 1" (3 trials) and "Guselkumab Dose 2" (3 trials). Other intervention names were less common.

The vast majority of trials in "Zvezdara University Medical Center" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Zvezdara University Medical Center". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in Zvezdara University Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Zvezdara University Medical Center, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".